Watch for Eysuvis and Other Steroid Drops for Dry Eyes

January 2021

Rx Eysuvis (loteprednol 0.25% suspension) will be the first FDA-approved ophthalmic corticosteroid for treating dry eyes.

But it’s only for up to 2 weeks of use.

We know long-term use of any ophthalmic steroid can increase the risk of glaucoma or cataracts...regardless of the steroid, strength, or formulation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote